ESALF
Price
$31.10
Change
+$0.10 (+0.32%)
Updated
Aug 15 closing price
Capitalization
8.89B
KHTRF
Price
$4.66
Change
+$0.11 (+2.42%)
Updated
Aug 7 closing price
Capitalization
450.67M
Interact to see
Advertisement

ESALF vs KHTRF

Header iconESALF vs KHTRF Comparison
Open Charts ESALF vs KHTRFBanner chart's image
Eisai
Price$31.10
Change+$0.10 (+0.32%)
Volume$370
Capitalization8.89B
Knight Therapeutics
Price$4.66
Change+$0.11 (+2.42%)
Volume$520
Capitalization450.67M
ESALF vs KHTRF Comparison Chart in %
Loading...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESALF vs. KHTRF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESALF is a StrongBuy and KHTRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (ESALF: $31.10 vs. KHTRF: $4.66)
Brand notoriety: ESALF and KHTRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ESALF: 12% vs. KHTRF: 19%
Market capitalization -- ESALF: $8.89B vs. KHTRF: $450.67M
ESALF [@Pharmaceuticals: Generic] is valued at $8.89B. KHTRF’s [@Pharmaceuticals: Generic] market capitalization is $450.67M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESALF’s FA Score shows that 2 FA rating(s) are green whileKHTRF’s FA Score has 0 green FA rating(s).

  • ESALF’s FA Score: 2 green, 3 red.
  • KHTRF’s FA Score: 0 green, 5 red.
According to our system of comparison, ESALF is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESALF’s TA Score shows that 5 TA indicator(s) are bullish while KHTRF’s TA Score has 4 bullish TA indicator(s).

  • ESALF’s TA Score: 5 bullish, 4 bearish.
  • KHTRF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KHTRF is a better buy in the short-term than ESALF.

Price Growth

ESALF (@Pharmaceuticals: Generic) experienced а +3.67% price change this week, while KHTRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($8.89B) has a higher market cap than KHTRF($451M). KHTRF has higher P/E ratio than ESALF: KHTRF (62.66) vs ESALF (27.95). KHTRF YTD gains are higher at: 29.086 vs. ESALF (21.059). ESALF has higher annual earnings (EBITDA): 101B vs. KHTRF (69.3M). ESALF has more cash in the bank: 269B vs. KHTRF (181M). KHTRF has less debt than ESALF: KHTRF (53.9M) vs ESALF (183B). ESALF has higher revenues than KHTRF: ESALF (753B) vs KHTRF (373M).
ESALFKHTRFESALF / KHTRF
Capitalization8.89B451M1,972%
EBITDA101B69.3M145,743%
Gain YTD21.05929.08672%
P/E Ratio27.9562.6645%
Revenue753B373M201,877%
Total Cash269B181M148,619%
Total Debt183B53.9M339,518%
FUNDAMENTALS RATINGS
ESALF vs KHTRF: Fundamental Ratings
ESALF
KHTRF
OUTLOOK RATING
1..100
3132
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
690
PRICE GROWTH RATING
1..100
4749
P/E GROWTH RATING
1..100
9296
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (9) in the null industry is somewhat better than the same rating for KHTRF (72). This means that ESALF’s stock grew somewhat faster than KHTRF’s over the last 12 months.

ESALF's Profit vs Risk Rating (100) in the null industry is in the same range as KHTRF (100). This means that ESALF’s stock grew similarly to KHTRF’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is significantly better than the same rating for KHTRF (90). This means that ESALF’s stock grew significantly faster than KHTRF’s over the last 12 months.

ESALF's Price Growth Rating (47) in the null industry is in the same range as KHTRF (49). This means that ESALF’s stock grew similarly to KHTRF’s over the last 12 months.

ESALF's P/E Growth Rating (92) in the null industry is in the same range as KHTRF (96). This means that ESALF’s stock grew similarly to KHTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESALFKHTRF
RSI
ODDS (%)
Bearish Trend 3 days ago
33%
Bearish Trend 3 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
48%
Momentum
ODDS (%)
Bullish Trend 3 days ago
36%
Bullish Trend 7 days ago
46%
MACD
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
37%
Bullish Trend 3 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
39%
Advances
ODDS (%)
Bullish Trend 17 days ago
38%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
49%
Aroon
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
37%
View a ticker or compare two or three
Interact to see
Advertisement
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCEBX9.850.20
+2.07%
Goldman Sachs Clean Energy Income A
NMGAX18.750.03
+0.16%
Neuberger Berman Mid Cap Growth A
PPQJX3.64N/A
N/A
Principal MidCap Growth III J
OCSGX7.00-0.01
-0.14%
Optimum Small-Mid Cap Growth C
VSEQX38.76-0.13
-0.33%
Vanguard Strategic Equity Inv

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
+0.32%
ESAIY - ESALF
30%
Poorly correlated
+2.73%
KHTRF - ESALF
27%
Poorly correlated
N/A
DVAX - ESALF
22%
Poorly correlated
+1.60%
BLMH - ESALF
20%
Poorly correlated
-5.98%
DBCCF - ESALF
15%
Poorly correlated
+5.57%
More

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and ESALF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
ESALF - KHTRF
27%
Poorly correlated
+0.32%
OVATF - KHTRF
25%
Poorly correlated
N/A
TAK - KHTRF
22%
Poorly correlated
+1.35%
JUSHF - KHTRF
13%
Poorly correlated
-10.65%
HYPMY - KHTRF
8%
Poorly correlated
+4.58%
More